China Headache and Vertigo Registry Study
Recruiting · NCT04939922 · Observational (researchers observe without assigning treatment) · Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
View the official record on ClinicalTrials.gov →What this trial is about
In the Chinese Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.
Who can take part
Inclusion criteria
- Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
- Male or female participants ages 4 to 99 years.
- Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches.
- Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).
Exclusion criteria
- Patients who were unable to complete scales such as headache diary.
- Patients denied or unable to be admitted for long-term follow-up.
Where it is running
2 locations listed.
- Kaiming Liu - Hangzhou, Zhejiang, China
- Kaiming Liu - Hangzhou, Zhejiang, China